The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
MYCN and the epigenome
Open accessAbstract
It is well known that Neuroblastoma (NB) patients whose tumors have an undifferentiated histology and a transcriptome enriched in cell cycle genes have a worse prognosis. This contrasts with the good prognoses of patients whose tumors have histologic evidence of differentiation and a transcriptome enriched in differentiation genes. Tumor cell lines from poor prognosis, high-risk patients contain a number of genetic alterations, including amplification of MYCN, 1pLOH, and unbalanced 11q or gains of Chr 17 and 7, and exhibit uncontrolled growth and an undifferentiated phenotype in in vitro culture. Yet treatment of such NB cell lines with retinoic acid results in growth control and induction of differentiation. This indicates that the signaling pathways that regulate cell growth and differentiation are not functionally lost but dysregulated. Agents such as retinoic acid normalize the signaling pathways and impose growth control and induction of differentiation. Recent studies in embryonic stem cells indicate that polycomb repressor complex proteins (PRC1 and PRC2) play a major role in regulating stem cell lineage specification and coordinating the shift from a transcriptome that supports self-renewal or growth to one that specifies lineage and controls growth. We have shown that in NB, the PRC2 complex is elevated in undifferentiated NB tumors and functions to suppress a number of tumor suppressor genes. This study will review the role of MYC genes in regulating the epigenome in normal development and explore how this role may be altered during tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Bernstein, B. E., Meissner, A., & Lander, E. S. (2007) · Cell · doi:10.1016/j.cell.2007.01.033 · Cited by 2,086
Structure and ligand of a histone acetyltransferase bromodomain
Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M. (1999) · Nature · doi:10.1038/20974 · Cited by 1,732 · cited 1×
“For example, acetylated histones serve as docking sites for bromodomain (Br) containing proteins (Dhalluin et al., 1999; Dey et al., 2003).”
BackgroundPioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Lin, C. Y., Lovén, J., Rahl, P. B., Paranal, R. M., Burge, C. B., Bradner, J. E., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.08.026 · Cited by 1,513
Schwab, M., Alitalo, K., Klempnauer, K.-H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., & Trent, J. (1983) · Nature · doi:10.1038/305245a0 · Cited by 1,407
Mechanisms of Polycomb gene silencing: knowns and unknowns
Simon, J. A., & Kingston, R. E. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2763 · Cited by 1,317
c-Myc Regulates Transcriptional Pause Release
Rahl, P. B., Lin, C. Y., Seila, A. C., Flynn, R. A., McCuine, S., Burge, C. B., Sharp, P. A., & Young, R. A. (2010) · Cell · doi:10.1016/j.cell.2010.03.030 · Cited by 1,279
Opening of Compacted Chromatin by Early Developmental Transcription Factors HNF3 (FoxA) and GATA-4
Cirillo, L. A., Lin, F. R., Cuesta, I., Friedman, D., Jarnik, M., & Zaret, K. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00459-8 · Cited by 1,185
p300/CBP proteins: HATs for transcriptional bridges and scaffolds
Chan, H. M., & La Thangue, N. B. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.13.2363 · Cited by 1,092
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
Nie, Z., Hu, G., Wei, G., Cui, K., Yamane, A., Resch, W., Wang, R., Green, D. R., Tessarollo, L., Casellas, R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.033 · Cited by 1,075
Systematic Protein Location Mapping Reveals Five Principal Chromatin Types in Drosophila Cells
Filion, G. J., van Bemmel, J. G., Braunschweig, U., Talhout, W., Kind, J., Ward, L. D., Brugman, W., de Castro, I. J., Kerkhoven, R. M., Bussemaker, H. J., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.009 · Cited by 964
Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression
Laherty, C. D., Yang, W.-M., Sun, J.-M., Davie, J. R., Seto, E., & Eisenman, R. N. (1997) · Cell · doi:10.1016/s0092-8674(00)80215-9 · Cited by 938
Soufi, A., Donahue, G., & Zaret, K. S. (2012) · Cell · doi:10.1016/j.cell.2012.09.045 · Cited by 933
The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins
McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., & Cole, M. D. (1998) · Cell · doi:10.1016/s0092-8674(00)81479-8 · Cited by 693
Kim, J., Woo, A. J., Chu, J., Snow, J. W., Fujiwara, Y., Kim, C. G., Cantor, A. B., & Orkin, S. H. (2010) · Cell · doi:10.1016/j.cell.2010.09.010 · Cited by 669
The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis
Dey, A., Chitsaz, F., Abbasi, A., Misteli, T., & Ozato, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1433065100 · Cited by 669
Thiele, C. J., Reynolds, C. P., & Israel, M. A. (1985) · Nature · doi:10.1038/313404a0 · Cited by 642
Self-citationThe essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
McMahon, S. B., Wood, M. A., & Cole, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.556-562.2000 · Cited by 494
Allard, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.18.5108 · Cited by 460
Definition of regions in human c-myc that are involved in transformation and nuclear localization.
Stone, J., de Lange, T., Ramsay, G., Jakobovits, E., Bishop, J. M., Varmus, H., & Lee, W. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1697 · Cited by 447
MYC recruits the TIP60 histone acetyltransferase complex to chromatin
Frank, S. R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H., Livingston, D. M., & Amati, B. (2003) · EMBO reports · doi:10.1038/sj.embor.embor861 · Cited by 405
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation
Wu, C.-H., van Riggelen, J., Yetil, A., Fan, A. C., Bachireddy, P., & Felsher, D. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701953104 · Cited by 403
c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function
Cheng, S.-W. G., Davies, K. P., Yung, E., Beltran, R. J., Yu, J., & Kalpana, G. V. (1999) · Nature Genetics · doi:10.1038/8811 · Cited by 396
Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription
Bisgrove, D. A., Mahmoudi, T., Henklein, P., & Verdin, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705053104 · Cited by 387
Myc influences global chromatin structure
Knoepfler, P. S., Zhang, X., Cheng, P. F., Gafken, P. R., McMahon, S. B., & Eisenman, R. N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601152 · Cited by 383
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
Ott, C. J., Kopp, N., Bird, L., Paranal, R. M., Qi, J., Bowman, T., Rodig, S. J., Kung, A. L., Bradner, J. E., & Weinstock, D. M. (2012) · Blood · doi:10.1182/blood-2012-02-413021 · Cited by 374
Myc-binding-site recognition in the human genome is determined by chromatin context
Guccione, E., Martinato, F., Finocchiaro, G., Luzi, L., Tizzoni, L., Dall' Olio, V., Zardo, G., Nervi, C., Bernard, L., & Amati, B. (2006) · Nature Cell Biology · doi:10.1038/ncb1434 · Cited by 366
Sin Meets NuRD and Other Tails of Repression
Knoepfler, P. S., & Eisenman, R. N. (1999) · Cell · doi:10.1016/s0092-8674(00)81531-7 · Cited by 356
The c-MYC Oncoprotein Is a Substrate of the Acetyltransferases hGCN5/PCAF and TIP60
Patel, J. H., Du, Y., Ard, P. G., Phillips, C., Carella, B., Chen, C.-J., Rakowski, C., Chatterjee, C., Lieberman, P. M., Lane, W. S., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10826-10834.2004 · Cited by 354
N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation
Malynn, B. A., de Alboran, I. M., O'Hagan, R. C., Bronson, R., Davidson, L., DePinho, R. A., & Alt, F. W. (2000) · Genes & Development · doi:10.1101/gad.14.11.1390 · Cited by 335
An ATPase/Helicase Complex Is an Essential Cofactor for Oncogenic Transformation by c-Myc
Wood, M. A., McMahon, S. B., & Cole, M. D. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80427-x · Cited by 310
Stimulation of c‐MYC transcriptional activity and acetylation by recruitment of the cofactor CBP
Vervoorts, J., Lüscher‐Firzlaff, J. M., Rottmann, S., Lilischkis, R., Walsemann, G., Dohmann, K., Austen, M., & Lüscher, B. (2003) · EMBO reports · doi:10.1038/sj.embor.embor821 · Cited by 281
Histone deacetylases: transcriptional repression with SINers and NuRDs
Ayer, D. E. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01536-6 · Cited by 274 · cited 1×
“MAD is able to recruit histone deacetylases (HDACs), via SIN3 a transcriptional corepressor, to target loci to induce transcriptional silencing (Laherty et al., 1997; Ayer, 1999; Knoepfler and Eisenman, 1999).”
BackgroundFunctional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
Valentijn, L. J., Koster, J., Haneveld, F., Aissa, R. A., van Sluis, P., Broekmans, M. E. C., Molenaar, J. J., van Nes, J., & Versteeg, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208215109 · Cited by 228
Nucleosomal Elements that Control the Topography of the Barrier to Transcription
Bintu, L., Ishibashi, T., Dangkulwanich, M., Wu, Y.-Y., Lubkowska, L., Kashlev, M., & Bustamante, C. (2012) · Cell · doi:10.1016/j.cell.2012.10.009 · Cited by 192
EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1 , CLU , RUNX3 , and NGFR
Wang, C., Liu, Z., Woo, C.-W., Li, Z., Wang, L., Wei, J. S., Marquez, V. E., Bates, S. E., Jin, Q., Khan, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-0961 · Cited by 175
Self-citationTranscription-independent functions of MYC: regulation of translation and DNA replication
Cole, M. D., & Cowling, V. H. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2467 · Cited by 159
Bmi-1 Is Essential for the Tumorigenicity of Neuroblastoma Cells
Cui, H., Hu, B., Li, T., Ma, J., Alam, G. N., Gunning, W. T., & Ding, H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060754 · Cited by 140
Cotterman, R. F., Jin, V. X., Krig, S. R., Lemen, J. M., Wey, A., Farnham, P., & Knoepfler, P. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1961 · Cited by 138
Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein
Zhang, X.-Y., DeSalle, L. M., Patel, J. H., Capobianco, A. J., Yu, D., Thomas‐Tikhonenko, A., & McMahon, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502330102 · Cited by 121
Epigenetic Changes in Pediatric Solid Tumors: Promising New Targets
Lawlor, E. R., & Thiele, C. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1921 · Cited by 120
Self-citationMcEwan, I. J., Dahlman‐Wright, K., Ford, J., & Wright, A. P. H. (1996) · Biochemistry · doi:10.1021/bi960793v · Cited by 109
Iraci, N., Diolaiti, D., Papa, A., Porro, A., Valli, E., Gherardi, S., Herold, S., Eilers, M., Bernardoni, R., Valle, G. D., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2627 · Cited by 100
Neri, F., Zippo, A., Křepelová, A., Cherubini, A., Rocchigiani, M., & Oliviero, S. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06148-11 · Cited by 97
Romero, O. A., Setién, F., John, S., Giménez‐Xavier, P., Goméz-López, G., Pisano, D. G., Condom, E., Villanueva, A., Hager, G. L., & Sánchez‐Céspedes, M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200236 · Cited by 90
Ochiai, H., Takenobu, H., Nakagawa, A., Yamaguchi, Y., Kimura, M., Ohira, M., Okimoto, Y., Fujimura, Y., Koseki, H., Kohno, Y., et al. (2010) · Oncogene · doi:10.1038/onc.2010.22 · Cited by 85
Polycomb Repressive Complex 1 (PRC1) Disassembles RNA Polymerase II Preinitiation Complexes
Lehmann, L. W., Ferrari, R., Vashisht, A. A., Wohlschlegel, J. A., Kurdistani, S. K., & Carey, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397430 · Cited by 79
Calao, M., Sekyere, E. O., Cui, H., et al. (2012) · Oncogene · doi:10.1038/onc.2012.368 · Cited by 68
Lucarelli, E., Kaplan, D. R., & Thiele, C. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24725 · Cited by 64
Self-citationN-Myc and GCN5 Regulate Significantly Overlapping Transcriptional Programs in Neural Stem Cells
Martínez‐Cerdeño, V., Lemen, J. M., Chan, V., Wey, A., Lin, W., Dent, S., & Knoepfler, P. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039456 · Cited by 63
Myc Regulation of mRNA Cap Methylation
Cowling, V. H., & Cole, M. D. (2010) · Genes & Cancer · doi:10.1177/1947601910378025 · Cited by 36
Cited by
Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C. L., Meier, W., Shapira-Frommer, R., Safra, T., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70228-1 · Cited by 1,442
Oza, A. M., Cibula, D., Benzaquen, A. O., Poole, C., Mathijssen, R. H. J., Sonke, G. S., Colombo, N., Špaček, J., Vuylsteke, P., Hirte, H., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71135-0 · Cited by 547
Advances in targeting the folate receptor in the treatment/imaging of cancers
Fernández, M., Javaid, F., & Chudasama, V. (2018) · Chemical Science · doi:10.1039/c7sc04004k · Cited by 539
The interplay of ROS and the PI3K/Akt pathway in autophagy regulation
Kma, L., & Baruah, T. J. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2104 · Cited by 394
Overchuk, M., & Zheng, G. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.024 · Cited by 383
Metadata
- Authors
- He, S., Liu, Z., Oh, D.-Y., & Thiele, C. J.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 3
- Pages
- 1-1
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2161225385
- Cited by
- 325
- References
- 54
- FWCI
- 25.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.